BlackRock Investment Management, LLC - IDERA PHARMACEUTICALS INC ownership

IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 90 filers reported holding IDERA PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.91 and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of IDERA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$552,000
-40.4%
367,938
+1.7%
0.00%0.0%
Q3 2016$926,000
+80.9%
361,750
+8.2%
0.00%0.0%
Q2 2016$512,000
-17.0%
334,389
+7.3%
0.00%0.0%
Q1 2016$617,000
-35.0%
311,598
+1.5%
0.00%0.0%
Q4 2015$949,000
-7.0%
307,084
+0.9%
0.00%0.0%
Q3 2015$1,020,000
-10.1%
304,334
-0.5%
0.00%0.0%
Q2 2015$1,134,000
+21.8%
305,782
+21.8%
0.00%0.0%
Q1 2015$931,000
+18.8%
250,998
+41.2%
0.00%0.0%
Q4 2014$784,000
+90.3%
177,788
-1.1%
0.00%0.0%
Q3 2014$412,000
-18.6%
179,745
+3.0%
0.00%0.0%
Q2 2014$506,000174,4310.00%
Other shareholders
IDERA PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Virtus ETF Advisers LLC 474,609$626,0000.55%
Kassirer Asset Management Corp 325,800$430,0000.28%
CORRADO ADVISORS, LLC 104,850$138,0000.08%
Artal Group S.A. 2,750,000$3,630,0000.08%
ROPES WEALTH ADVISORS LLC 100,000$132,0000.04%
MYCIO WEALTH PARTNERS, LLC 246,527$325,0000.03%
Palo Alto Investors LP 616,355$814,0000.03%
HOLLENCREST CAPITAL MANAGEMENT 172,570$228,0000.03%
LAU ASSOCIATES LLC 26,713$35,0000.02%
NATIXIS 3,438,529$4,539,0000.02%
View complete list of IDERA PHARMACEUTICALS INC shareholders